Buy Now
Angiography Devices Market Size, Share, Growth & Industry Analysis, By Product (Systems, Consumables), By Technology (X-Ray, MRA, CT, Others), By Application (Coronary, Endovascular, Neurovascular, Cerebral, Others), By End User and Regional Analysis, 2025-2032
Pages: 190 | Base Year: 2024 | Release: July 2025 | Author: Versha V.
Angiography devices are medical imaging tools used to visualize blood vessels and internal organs, primarily to identify blockages, abnormalities, or vascular conditions. The market includes angiography systems, catheters, guide wires, contrast media injectors, and related accessories, supporting diagnostic and interventional procedures in hospitals, clinics, and specialized cardiovascular centers.
The report outlines the primary drivers of market growth, along with an in-depth analysis of emerging trends and evolving regulatory frameworks shaping the industry's trajectory.
The global angiography devices market size was valued at USD 10.54 billion in 2024 and is projected to grow from USD 10.96 billion in 2025 to USD 15.18 billion by 2032, exhibiting a CAGR of 4.54% during the forecast period.
The market is expanding due to the increased use of advanced imaging in diagnostic and interventional procedures. Growing awareness of preventive care and the rise in image-guided treatments are fueling adoption. Healthcare providers are focusing on early and accurate detection of vascular conditions.
Major companies operating in the angiography devices industry are Siemens AG, General Electric Company, Koninklijke Philips N.V., Canon Inc., Shimadzu Corporation, Omega Medical Imaging, LLC, Allengers, Boston Scientific Corporation, AngioDynamics, Abbott, B. Braun SE, Cordis, TERUMO CORPORATION, Merit Medical Systems, and Alvimedica.
The integration of advanced imaging technologies in cancer care is expanding access to high-precision diagnostics and treatment, particularly in emerging healthcare markets. These technologies are revolutionizing the detection and management of complex conditions by enabling real-time visualization, reduced procedural risk, and improved therapeutic outcomes.
Market Driver
Surging Adoption of Minimally Invasive Interventions
The market is witnessing strong growth due to the increasing adoption of minimally invasive, image-guided procedures. These techniques reduce surgical risks, shorten hospital stays, and improve patient outcomes, making them a preferred choice for both clinicians and patients.
As the focus shifts toward accuracy and efficiency in vascular diagnostics and treatment, there is a rising demand for high-precision angiography systems. These systems provide real-time, detailed imaging that enhances procedural control and decision-making.
The transition to advanced interventional methods is compelling healthcare providers to invest in next-generation angiography equipment, which is accelerating market expansion.
Market Challenge
Diagnostic Limitations in Microvascular Imaging
A major challenge hindering the expansion of the angiography devices market is the limited diagnostic accuracy in detecting microvascular disease, particularly in early or asymptomatic stages.
Conventional imaging techniques often lack the resolution and sensitivity to visualize small vessels and subtle abnormalities, which can result in delayed diagnosis or misinterpretation. This diagnostic limitation negatively impacts the success of interventional procedures and can lead to suboptimal patient outcomes.
To address this, manufacturers are integrating AI-enhanced imaging technologies into angiography systems. These innovations offer superior image clarity, automated detection, and real-time analysis, allowing clinicians to identify microvascular conditions with greater precision and efficiency. This advancement is improving diagnostic confidence and enabling more accurate, personalized treatment planning.
Market Trend
Integration of Robotic Imaging Systems in Hybrid Surgical Settings
The market is witnessing a notable shift toward the use of advanced imaging technologies in hybrid operating room (OR) settings. This trend is further supported by the installation of fixed robotic angiography systems that offer enhanced precision and control.
These systems are increasingly being integrated into multi-functional surgical environments to support a wide range of vascular and endovascular procedures. The hybrid OR model enables seamless collaboration between surgical and imaging functions, improving workflow efficiency.
This trend reflects the broader move toward image-guided, minimally invasive interventions that demand high-resolution, real-time visualization capabilities.
|
Segmentation |
Details |
|
By Product |
Systems, Consumables (Catheters, Guidewire, Contrast Media, Vascular Closure Devices, Accessories) |
|
By Technology |
X-Ray, MRA, CT, Others |
|
By Application |
Coronary, Endovascular, Neurovascular, Cerebral, Others |
|
By End User |
Hospitals, Diagnostic Centers, Ambulatory Surgical Centers |
|
By Region |
North America: U.S., Canada, Mexico |
|
Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe |
|
|
Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific |
|
|
Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa |
|
|
South America: Brazil, Argentina, Rest of South America |
Market Segmentation
Based on region, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The North America angiography devices market accounted for a substantial share of 34.09% in 2024, valued at USD 3.59 billion. This dominance is reinforced by the high volume of cardiovascular and neurovascular procedures, supported by the early adoption of advanced imaging systems and strong healthcare infrastructure across the U.S. and Canada. Continued investment in precision-guided therapies and digital integration further supported regional market growth.
This initiative exemplifies North America’s innovation-driven approach, enabling non-invasive, angiography-based coronary physiology assessments that enhance diagnostic accuracy, improve workflow efficiency, and reduce reliance on invasive pressure wires in interventional cardiology. Such collaborations strengthen the region's leadership in technological advancement and clinical excellence in angiography .
The Asia-Pacific angiography devices industry is expected to register the fastest CAGR of 5.51% over the forecast period. This growth is propelled by rapid urbanization and the increasing prevalence of cardiovascular diseases, supported by changing lifestyles and dietary habits.
This has led to the increased demand for advanced diagnostic tools. Rising healthcare infrastructure investments, particularly in emerging economies such as India and Southeast Asia, have expanded access to specialized cardiovascular care. Additionally, growing awareness among patients about early diagnosis and minimally invasive procedures has fueled the adoption of angiography devices.
This growth is further aided by the expanding medical tourism industry, as patients seek cost-effective, high-quality cardiac treatments. Furthermore, increasing availability of skilled healthcare professionals and advancements in local manufacturing have improved affordability and accessibility of these devices across the region.
The angiography devices market is characterized by key players adopting strategies to strengthen their market presence. Leading companies are focusing on expanding their product portfolios through the development of advanced and minimally invasive imaging technologies.
Strategic collaborations and partnerships with healthcare providers and research institutions are fostering innovation and boosting clinical adoption. Market participants also prioritize geographic expansion to tap into emerging markets, often through the establishment of regional subsidiaries and distribution networks.
Additionally, mergers and acquisitions are frequently employed to acquire new technologies, enhance manufacturing capabilities, and increase market share.
Recent Developments (Product Launch)
